CA
NZ
UK
AU
IND
US
…
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Oaktree Acquisition Corp. III is a NASDAQ-listed special purpose acquisition company formed to combine with a life sciences business and holds cash in trust until a merger. Growth may be driven by providing public-market access to innovative therapeutics or diagnostics and by Oaktree's capital-markets experience, which could support exposure to late-stage private life sciences assets.
Key risks include SPAC-specific uncertainties such as lack of an operating business until a deal, deal execution and dilution risk, plus life-sciences regulatory and clinical-development risk that could materially affect post-combination value.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 |
| Income before tax | 7.29M | 0.00M |
| Net income | 7.29M | 0.00M |
| Selling general administrative | 1.20M | 0.00M |
| Ebit | - | -0.35M |
| Ebitda | -1.20M | -0.35M |
| Depreciation and amortization | - | 0.00M |
| Operating income | -1.20M | -0.00M |
| Other operating expenses | 1.20M | 0.00M |
| Interest income | 8.48M | - |
| Net interest income | 8.48M | - |
| Total revenue | 0.00M | - |
| Total operating expenses | 1.20M | 0.00M |
| Total other income expense net | 8.48M | 0.00M |
| Net income from continuing ops | 7.29M | - |
| Breakdown | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 |
| Total assets | 203.11M | 195.25M |
| Other current assets | 0.11M | 0.20M |
| Total liab | 8.32M | 7.75M |
| Total stockholder equity | 194.79M | 187.50M |
| Other current liab | 1.29M | 0.72M |
| Common stock | 201.56M | 193.58M |
| Capital stock | 201.56M | 193.58M |
| Retained earnings | -6.77M | -6.08M |
| Cash | 1.43M | 1.36M |
| Total current liabilities | 1.30M | 0.73M |
| Net debt | -1.42M | -1.35M |
| Short term debt | 0.01M | 0.01M |
| Short long term debt | 0.01M | 0.01M |
| Short long term debt total | 0.01M | 0.01M |
| Total current assets | 1.55M | 1.56M |
| Accounts payable | 0.50M | 0.54M |
| Non currrent assets other | 201.56M | 0.11M |
| Non current assets total | 201.56M | 193.69M |
| Breakdown | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 |
| Total cashflows from investing activities | 0.50M | -191.99M |
| Net borrowings | 0.00M | - |
| Total cash from financing activities | 0.00M | 193.44M |
| Net income | 7.29M | 0.00M |
| Change in cash | 0.08M | 1.36M |
| Begin period cash flow | 1.36M | - |
| End period cash flow | 1.43M | 1.36M |
| Total cash from operating activities | -0.42M | -0.09M |
| Issuance of capital stock | 0.00M | - |
| Other cashflows from investing activities | 0.50M | -0.38M |
| Other cashflows from financing activities | - | 0.39M |
| Capital expenditures | 0.00M | 0.00M |
| Change in working capital | 0.77M | -0.00M |
| Other non cash items | -8.48M | -0.09M |
| Free cash flow | -0.42M | -0.00M |
Sector: Financial Services Industry: Shell Companies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| OACC Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share |
- -% |
10.70 | 38.47 | - | - | 1.34 |
| CLUS CLUS |
- -% |
200.00 | - | - | 0.09 | 0.92 |
| SGDH Sgd Holdings Ltd |
- -% |
0.11 | - | - | 59741.55 | 0.56 |
| LION Lionsgate Studios Holding Corp. |
0.02 0.14% |
14.39 | - | 23.31 | 1.13 | 1.35 |
| QKIE QKIE |
- -% |
1.94 | - | - | 470.20 | - |
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
333 South Grand Avenue, Los Angeles, CA, United States, 90071
213 830 6300
| Name | Title | Year Born |
|---|---|---|
| Mr. Zaid Pardesi | CEO & Director | 1983 |
| Mr. George A. Martinez | CFO, Principal Accounting & Principal Financial Officer | 1985 |
| Mr. Mathew M. Pendo | Chief Operation Officer | 1964 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.06%
Communication Services
+0.16%
Consumer Cyclical
-0.27%
Consumer Defensive
-0.26%
Energy
+1.15%
Financial Services
+0.01%
Financials
-0.13%
Healthcare
+0.15%
Industrials
+0.31%
Real Estate
-0.28%
Technology
+1.73%
Utilities
-0.24%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...